ML20053C651
| ML20053C651 | |
| Person / Time | |
|---|---|
| Issue date: | 05/26/1982 |
| From: | Douglas R, Sreniawski D NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION III) |
| To: | |
| Shared Package | |
| ML20053C646 | List: |
| References | |
| NUDOCS 8206020429 | |
| Download: ML20053C651 (2) | |
Text
.
U.S. NUCLEAR REGULATORY C0K4ISSION OFFICE OF INSPECTION AND ENFORCEMENT REGION III Report-No. 82-01 License No. 34-11870-01 Priority:
IV Category: G2-7 Licensee:
Sol Taplits, M.D.
2198 Losantiville Road Cincinnati, Ohio 45237 Inspection Conducted: March 21,1982 (Telephone Contact Only) b,/d f
Inspector:
b dou 1
/
StA
[-}&-[ k Approved By:
D. J. Sreniaw ai, Chief Materials Radiation Protection Section 2 Inspection Summary Inspection on March ~21,'1982 (Report No.'82-01).
Areas Inspected: Review of license file to determine status of license.
'Results: Material procured by licensee was of small amounts and has been depleted.
1 8206020429 820527 NMS LIC30 34-11870-01 PDR
DETAILS 1.
Persons Contacted I
Dr. S. Taplits 2.
Source of Information Dr. S. Taplits and license file 3.
Scope of Program License authorized use of amounts as necessary of Byproduct Material from Group I and Il for diagnostic procedures, 30 millicuries of iodine-131 for treatment of hyperthyroidism and cardiac dysfunction, 20 millicuries of phosphorus-32 for treatment of leukemia, polycy-themia vera and bone metastases and also phosphorus-32 for intra-cavitary treatment.
4.
Status of Program Material procured for program has been depleted and the amounts and half lifes of Byproduct Material used warrant no additional followup.
5.
Conclusion Based on statements made by Dr. _'laplits, and the completed NRC-314, material procured by licensee has been depleted.